Fool.com contributor Parkev Tatevosian evaluates Hims & Hers Health (HIMS 2.25%) stock for long-term investors.
*Stock prices used were the afternoon prices of June 20, 2024. The video was published on June 22, 2024.

The telehealth company is offering innovative products at lower prices.
Fool.com contributor Parkev Tatevosian evaluates Hims & Hers Health (HIMS 2.25%) stock for long-term investors.
*Stock prices used were the afternoon prices of June 20, 2024. The video was published on June 22, 2024.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.